Drug Repurposing for COVID-19 via Knowledge Graph Completion

Abstract

Objective: To discover candidate drugs to repurpose for COVID-19 using literature-derived knowledge and knowledge graph completion methods. Methods: We propose a novel, integrative, and neural network-based literature-based discovery (LBD) approach to identify drug candidates from both PubMed and COVID-19-focused research literature. Our approach relies on semantic triples extracted using SemRep (via SemMedDB). We identified an informative subset of semantic triples using filtering rules and an accuracy classifier developed on a BERT variant, and used this subset to construct a knowledge graph. Five SOTA, neural knowledge graph completion algorithms were used to predict drug repurposing candidates. The models were trained and assessed using a time slicing approach and the predicted drugs were compared with a list of drugs reported in the literature and evaluated in clinical trials. These models were complemented by a discovery pattern-based approach. Results: Accuracy classifier based on PubMedBERT achieved the best performance (F1= 0.854) in classifying semantic predications. Among five knowledge graph completion models, TransE outperformed others (MR = 0.923, Hits@1=0.417). Some known drugs linked to COVID-19 in the literature were identified, as well as some candidate drugs that have not yet been studied. Discovery patterns enabled generation of plausible hypotheses regarding the relationships between the candidate drugs and COVID-19. Among them, five highly ranked and novel drugs (paclitaxel, SB 203580, alpha 2-antiplasmin, pyrrolidine dithiocarbamate, and butylated hydroxytoluene) with their mechanistic explanations were further discussed. Conclusion: We show that an LBD approach can be feasible for discovering drug candidates for COVID-19, and for generating mechanistic explanations. Our approach can be generalized to other diseases as well as to other clinical questions.

47 pages, 3 figures, Accepted to Journal of Biomedical Informatics

References in corpus (11)

• Adam: A Method for Stochastic Optimization
• BioBERT: a pre-trained biomedical language representation model for biomedical text mining
• Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing
• Modeling polypharmacy side effects with graph convolutional networks
• Complex Embeddings for Simple Link Prediction
• Publicly Available Clinical BERT Embeddings
• CORD-19: The COVID-19 Open Research Dataset
• KG-BERT: BERT for Knowledge Graph Completion
• Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
• DGL-KE: Training Knowledge Graph Embeddings at Scale
• Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs

Cited by in corpus (7)

• BERT Based Clinical Knowledge Extraction for Biomedical Knowledge Graph Construction and Analysis
• Neurosymbolic AI for Reasoning over Knowledge Graphs: A Survey
• Developing a Knowledge Graph Framework for Pharmacokinetic Natural Product-Drug Interactions
• Mining On Alzheimer's Diseases Related Knowledge Graph to Identity Potential AD-related Semantic Triples for Drug Repurposing
• Natural Language Processing for Drug Discovery Knowledge Graphs: promises and pitfalls
• Repurposing of Resources: from Everyday Problem Solving through to Crisis Management
• Discovering novel drug-supplement interactions using a dietary supplements knowledge graph generated from the biomedical literature